DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

What is the PE ratio of Biofil Chemicals & Pharmaceuticals Limited?

Biofil Chemicals & Pharmaceuticals Limited has a price-to-earnings (PE) ratio of 17.8 in the Healthcare sector.

What is the market capitalisation of Biofil Chemicals & Pharmaceuticals Limited?

Biofil Chemicals & Pharmaceuticals Limited has a market capitalisation of approximately ₹49 crore.

Is Biofil Chemicals & Pharmaceuticals Limited a profitable company?

Biofil Chemicals & Pharmaceuticals Limited generates a return on equity of 12.9% with a net profit margin of 9.8%. That is a reasonable return on shareholder capital.

What is the 52-week high and low of BIOFILCHEM?

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) has traded between ₹25.6 and ₹46.34 over the past 52 weeks, against a current price of ₹30.48.

Biofil Chemicals & Pharmaceuticals Limited

₹30.48▲ +0.58 (+1.94%)

BIOFILCHEM·NSE·Healthcare

Market Cap

48.84 Cr

PE Ratio

17.82

Volume

2,033

Day High - Low

30.73 - 29.62

52W High-Low

46.34 - 25.60

₹30.48▲ +0.58 (+1.94%)

Market Cap48.84 Cr

PE Ratio17.82

Volume2,033

Day High - Low30.73 - 29.62

52W High-Low46.34 - 25.60

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM): company summary

The company's annual net profit rose 398.2% to ₹3 crore, while annual revenue fell 15.0% to ₹28 crore.

Biofil Chemicals & Pharmaceuticals Limited (BIOFILCHEM) is a micro-cap Healthcare company valued at ₹49 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move: Biofil Chemicals & Pharmaceuticals Limited last traded at ₹30.48, modestly up 1.94% on the day.
Financial performance: The company's annual net profit rose 398.2% to ₹3 crore, while annual revenue fell 15.0% to ₹28 crore. The latest quarter showed revenue rose 92.1% year-on-year to ₹12 crore, but net profit fell 95.4% to ₹0 crore.
Valuation multiples: The stock trades at 17.8 times earnings, a discount to the Healthcare median of 32.0, 2.78 times book value.
Things to watch: The company's latest quarter net profit fell 95.4% to ₹0 crore. The company's net profit margin rose 8.1 percentage points to 9.8%, but it is not paying out dividend despite repeated profits.
Where it stands: The company's annual net profit rose sharply to ₹3 crore, but the latest quarter net profit fell to ₹0 crore. The company's net profit margin improved significantly, but it is not paying out dividend.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score

4.5/10

Weak

Fair Value

ROE

12.92%

Average

P/E

17.82x

Fair

Debt / Equity

0.14

Low

Industry

Healthcare

Pharmaceuticals

Overall View

Weak

Price performance

Day₹29.62

₹30.73

52W₹25.60

₹46.34

DocStoX take

Supported by risk (6.4), but held back by momentum (1.2).

DocStoX score

Low confidence

4.5

/10

Weak

Quality

Modest

ROE 12.9%

Valuation

Rich

P/E 17.8×

Growth

Steady

Revenue -4.5% 5Y CAGR

Risk

Moderate

D/E 0.14

Momentum

Weak

24% of 52-week range

DocStoX research

Our verdict

Fairly Valued

Fair value not available

Current price

₹30

Upside / Downside

—

Implied CAGR

—

Priced in by the market

Uncertainty

—

Est. confidence

At a glance

Market Cap

₹49 Cr

52W High / Low

₹46 / ₹26

Dividend Yield

0.00%

Promoter Holding

46.79%

EPS (TTM)

₹1.71

Book Value

₹13.25

Key highlights

Low leverage — D/E 0.14
Profitable in all of the last 5 years
Profit compounding 18% a year
Revenue shrinking 5% a year
Momentum is weak (1.2/10)

3 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Explore Biofil Chemicals & Pharmaceuticals Limited’s valuation

Free deep-dive tools · no sign-up

Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.

Biofil Chemicals & Pharmaceuticals Limited peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Zydus Lifesciences Limited Laurus Labs Limited Cipla Limited Dr. Reddy's Laboratories Limited Aurobindo Pharma Limited Mankind Pharma Limited Lupin Limited Manipal Health Enterprises Limited

Compare Biofil Chemicals & Pharmaceuticals Limited with peers

Biofil Chemicals & Pharmaceuticals Limited vs Sun Pharmaceutical Industries Limited Biofil Chemicals & Pharmaceuticals Limited vs Divi's Laboratories Limited Biofil Chemicals & Pharmaceuticals Limited vs Torrent Pharmaceuticals Limited Biofil Chemicals & Pharmaceuticals Limited vs Apollo Hospitals Enterprise Limited Biofil Chemicals & Pharmaceuticals Limited vs Zydus Lifesciences Limited Biofil Chemicals & Pharmaceuticals Limited vs Laurus Labs Limited

Related tools & concepts

Value Biofil Chemicals & Pharmaceuticals Limited with the ratios and calculators DocStoX uses in its analysis.

P/E RatioPrice to earnings Return on Equity (ROE)Profitability ROCECapital efficiency Debt to EquityLeverage P/B RatioPrice to book Net Profit MarginBottom-line efficiency DCF / Intrinsic ValueEstimate fair value CAGR CalculatorAnnualised return Dividend YieldIncome on price Position SizeRisk-based sizing Brokerage CalculatorCharges on a trade SIP CalculatorSystematic investing

Explore further

BIOFILCHEM newsLatest coverage & filings Open screenerFilter the whole market